Cellosaurus S2-020 (CVCL_B281)

Cell line name S2-020
Synonyms SUIT2-020
Accession CVCL_B281
Resource Identification Initiative To cite this cell line use: S2-020 (RRID:CVCL_B281)
Comments Doubling time: 24.8 hours (PubMed=1391733).
Sequence variation: CDKN2A p.Glu69Ter (from parent cell line).
Sequence variation: KRAS p.Gly12Asp (from parent cell line).
Sequence variation: TP53 p.Arg273His (from parent cell line).
Disease Pancreatic ductal adenocarcinoma (NCIt: C9120)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_3172 (SUIT-2)
Sex of cell Male
Category Cancer cell line
STR profile Source(s): TKG

Markers:
AmelogeninX
CSF1PO11,12
D13S3179,11
D16S5399
D5S81811,12
D7S8209,11
TH016
TPOX8,10
vWA16,17
Publications

PubMed=1319859; DOI=10.1007/BF00133561
Taniguchi S., Iwamura T., Katsuki T.
Correlation between spontaneous metastatic potential and type I collagenolytic activity in a human pancreatic cancer cell line (SUIT-2) and sublines.
Clin. Exp. Metastasis 10:259-266(1992)

PubMed=1391733; DOI=10.1111/j.1440-1746.1992.tb01030.x
Iwamura T., Taniguchi S., Kitamura N., Yamanari H., Kojima A., Hidaka K., Setoguchi T., Katsuki T.
Correlation between CA19-9 production in vitro and histological grades of differentiation in vivo in clones isolated from a human pancreatic cancer cell line (SUIT-2).
J. Gastroenterol. Hepatol. 7:512-519(1992)

PubMed=11854916; DOI=10.3748/wjg.v7.i6.855
Liu B., Staren E., Iwamura T., Appert H., Howard J.
Taxotere resistance in SUIT. Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines.
World J. Gastroenterol. 7:855-859(2001)

Cross-references
Cell line collections TKG; TKG 0710